Literature DB >> 11691795

The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.

T Liu1, H Yan, S Kuismanen, A Percesepe, M L Bisgaard, M Pedroni, P Benatti, K W Kinzler, B Vogelstein, M Ponz de Leon, P Peltomäki, A Lindblom.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is attributable to a deficiency of mismatch repair. Inactivation of DNA mismatch repair underlies the genesis of microsatellite instability in colorectal cancer. Germline mutations in three DNA mismatch repair genes, hMSH2, hMLH1, and hMSH6, have been found to segregate in HNPCC and HNPCC-like families. The two DNA mismatch repair genes hPMS1 and hPMS2 have also been suggested to predispose to HNPCC. In this study, 84 HNPCC and HNPCC-like kindreds without known mutations in the other three known DNA mismatch repair genes were screened for germline mutations in the hPMS1 or hPMS2 gene. No clear-cut pathogenic mutations were identified. Conversion technology was used to detect a large hMSH2 deletion in two affected members of the kindred in which the hPMS1 mutation was originally reported, whereas the hPMS1 mutation was only present in one of these two individuals. Since the hPMS1 and hPMS2 genes were first reported, germline mutations in hPMS2 have been demonstrated primarily in patients with Turcot's syndrome. However, no mutation in any of the two genes has been found to segregate in HNPCC families. Until there is better evidence for an increased colorectal cancer risk associated with germline mutations in these genes, a conservative interpretation of the role of mutations in these genes is advised.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691795

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Regulation of the human MSH6 gene by the Sp1 transcription factor and alteration of promoter activity and expression by polymorphisms.

Authors:  Isabella Gazzoli; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

2.  Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.

Authors:  Graham Casey; Noralane M Lindor; Nickolas Papadopoulos; Stephen N Thibodeau; John Moskow; Scott Steelman; Carolyn H Buzin; Steve S Sommer; Christine E Collins; Malinda Butz; Melyssa Aronson; Steven Gallinger; Melissa A Barker; Joanne P Young; Jeremy R Jass; John L Hopper; Anh Diep; Bharati Bapat; Michael Salem; Daniela Seminara; Robert Haile
Journal:  JAMA       Date:  2005-02-16       Impact factor: 56.272

Review 3.  Genomics of adult and pediatric solid tumors.

Authors:  Zahraa Rahal; Farah Abdulhai; Humam Kadara; Raya Saab
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

4.  Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group.

Authors:  Marina J Corines; Jada G Hamilton; Emily Glogowski; Chris A Anrig; Rachael Goldberg; Kate Niehaus; Erin Salo-Mullen; Megan Harlan; Margaret R Sheehan; Magan Trottier; Asad Ahsraf; Christina Tran; Lauren Jacobs; Rohini Rau-Murthy; Anne G Lincoln; Mark E Robson; Jose G Guillem; Arnold J Markowitz; Kenneth Offit; Zsofia K Stadler
Journal:  J Genet Couns       Date:  2016-10-12       Impact factor: 2.537

5.  Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications.

Authors:  Aziz Zaanan; Katy Meunier; Fatiha Sangar; Jean-François Fléjou; Françoise Praz
Journal:  Cell Oncol (Dordr)       Date:  2011-04-12       Impact factor: 6.730

6.  The progression of the ClinGen gene clinical validity classification over time.

Authors:  Jennifer L McGlaughon; Jennifer L Goldstein; Courtney Thaxton; Sarah E Hemphill; Jonathan S Berg
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

Review 7.  Lynch syndrome genes.

Authors:  Päivi Peltomäki
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

8.  Aetiology of colorectal cancer and relevance of monogenic inheritance.

Authors:  M Ponz de Leon; P Benatti; F Borghi; M Pedroni; A Scarselli; C Di Gregorio; L Losi; A Viel; M Genuardi; G Abbati; G Rossi; M Menigatti; I Lamberti; G Ponti; L Roncucci
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.

Authors:  Michel De Vos; Bruce E Hayward; Susan Picton; Eamonn Sheridan; David T Bonthron
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

10.  Some aspects of molecular diagnostics in Lynch syndrome.

Authors:  Grzegorz Kurzawski
Journal:  Hered Cancer Clin Pract       Date:  2006-12-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.